Skip to main navigation Skip to search Skip to main content

Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies

  • Robert J. Morgan
  • , Edward M. Newman
  • , Lawrence Sowers
  • , Kevin Scanlon
  • , Jonathan Harrison
  • , Steven Akman
  • , Lucille Leong
  • , Kim Margolin
  • , Joyce Niland
  • , James Raschko
  • , George Somlo
  • , Mary Carroll
  • , Warren Chow
  • , Merry Tetef
  • , Victor Hamasaki
  • , Yun Yen
  • , James H. Doroshow

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)459-464
Number of pages6
JournalCancer Chemotherapy and Pharmacology
Volume51
Issue number6
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Keywords

  • AZT
  • Azidothymidine
  • Cisplatin
  • Phase I trial
  • Antineoplastic Agents/administration & dosage
  • Humans
  • Middle Aged
  • Neoplasms/drug therapy
  • Drug Resistance, Neoplasm
  • Male
  • Zidovudine/administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols/adverse effects
  • Cisplatin/administration & dosage
  • Adult
  • Female
  • Aged
  • Antimetabolites, Antineoplastic/administration & dosage

Cite this